BioCentury
ARTICLE | Company News

Avita sales and marketing update

March 14, 2016 7:00 AM UTC

Avita launched ReGenerCell and ReNovaCell in Europe. Both autologous cell harvesting devices have CE Mark approval. ReGenerCell is approved to treat chronic wounds, such as venous leg ulcers and diabetic foot ulcers. ReNovaCell is approved to treat scar revisions and conditions linked to pigmentation. ...